Back
Windtree Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
19
WINT
Windtree Therapeutics
Last Price:
$0.51
Seasonality Move:
-6.39%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and WINT is experiencing slight buying pressure.
Windtree Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.54 | Sell |
| 20-day SMA: | 0.74 | Sell |
| 50-day SMA: | 0.69 | Sell |
| 200-day SMA: | 8.02 | Sell |
| 8-day EMA: | 0.53 | Sell |
| 20-day EMA: | 0.42 | Buy |
| 50-day EMA: | 0.24 | Buy |
| 200-day EMA: | 0.07 | Buy |
Windtree Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 37.4 | Sell |
| Chaikin Money Flow: | -202094 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Windtree Therapeutics Technical Analysis
| Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Windtree Therapeutics Stock
Is Windtree Therapeutics Stock a Buy?
-
Windtree Therapeutics share price is 0.52 while WINT 8-day simple moving average is 0.54, which is a Sell signal.
-
The stock price of WINT is 0.52 while Windtree Therapeutics 20-day SMA is 0.74, which makes it a Sell.
-
Windtree Therapeutics 50-day simple moving average is 0.69 while WINT share price is 0.52, making it a Sell technically.
-
WINT stock price is 0.52 and Windtree Therapeutics 200-day simple moving average is 8.02, creating a Sell signal.
WINT Technical Analysis vs Fundamental Analysis
Sell
19
Windtree Therapeutics (WINT)
is a Sell
Is Windtree Therapeutics a Buy or a Sell?
-
Windtree Therapeutics stock is rated a SellThe current Windtree Therapeutics [WINT] share price is $0.52. The Score for WINT is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
Windtree Therapeutics Stock Info
Market Cap:
14.8M
Price in USD:
0.52
Share Volume:
1.1M
Windtree Therapeutics 52-Week Range
52-Week High:
663.44
52-Week Low:
0.36
Sell
19
Windtree Therapeutics (WINT)
is a Sell
Windtree Therapeutics Share Price Forecast
-
What is the Windtree Therapeutics stock price today?The Windtree Therapeutics stock price is 0.52 USD today.
-
Will WINT stock go up or go down?Windtree Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Windtree Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Windtree Therapeutics is overvalued.
Is Windtree Therapeutics Stock a Buy?
-
Windtree Therapeutics share price is 0.52 while WINT 8-day exponential moving average is 0.53, which is a Sell signal.
-
The stock price of WINT is 0.52 while Windtree Therapeutics 20-day EMA is 0.42, which makes it a Buy.
-
Windtree Therapeutics 50-day exponential moving average is 0.24 while WINT share price is 0.52, making it a Buy technically.
-
WINT stock price is 0.52 and Windtree Therapeutics 200-day simple moving average is 0.07, creating a Buy signal.
Fundamental Analysis of Windtree Therapeutics
Is Windtree Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $313.50 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Windtree Therapeutics
Should I short Windtree Therapeutics stock?
-
WINT Moving Average Covergence Divergence (MACD) indicator is 0.13, suggesting Windtree Therapeutics is a Buy
-
Windtree Therapeutics Relative Strength Index (RSI) is 37.4, which suggest Windtree Therapeutics is oversold
-
The Bollinger Bands (25) for Windtree Therapeutics is ( - ), which suggest Windtree Therapeutics is a Buy
-
The Bollinger Bands (100) for Windtree Therapeutics is ( - ), which suggest Windtree Therapeutics is a Buy
* Windtree Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.